March 01, 2008 Archives - Page 3 of 4 - Renal and Urology News

Print Issue: March 01, 2008

Welchol

Approval for Adjunctive Drug to Treat Type 2 Diabetes

The FDA has approved Welchol (colesevelam hydrochloride) to reduce blood glucose in adults with type 2 diabetes mellitus in combination with metformin, sulfonylureas, or insulin, either alone or in combination with other agents, according to Daiichi Sankyo, Inc., of Parsippany, N.J.

Improving Post-RRP Potency

Among men undergoing radical retropubic prostatectomy (RRP) for localized prostate cancer, younger age, bilateral nerve sparing, and good surgical technique improve the likelihood of a return to potency after surgery.

Hospitalizations May Lower Hct

SAN FRANCISCO—Dialysis patients hospitalized for infection, GI bleeding, or a major surgical procedure may experience a significant decline in hematocrit (Hct) levels, researchers say. The decline increases with length of stay.

Shirish Sangle, MD

Rituximab May Not Halt Progression to ESRD

BOSTON—Rituximab is highly effective for treating resistant systemic lupus erythematosus (SLE), but, in certain patients, the medication does not prevent progression to end-stage renal disease (ESRD), British researchers conclude.

The Kidney Transplant Tradeoff

Research developments that have implications for nephrology and urology certainly are not limited to the meetings and journals targeting these specialties. That is why our news coverage extends to meetings that nephrologists and urologists usually do not attend and journals they usually do not read.

Next post in Nutrition